Genomic characterization of organ metastasis in non-small cell lung cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400090746

Enrollment

Unknown

Registered

2024-10-12

Start date

2024-10-31

Completion date

Unknown

Last updated

2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

32 Years to 93 Years

Inclusion criteria

Inclusion criteria: Clear pathological diagnosis results of NSCLC (our hospital or other hospital) and the clinical pathological data were complete. Results of a large panel gene test with lung primary lesions. Initial treatment of patients.

Exclusion criteria

Exclusion criteria: The pathology was not the primary NSCLC. The pathological diagnosis had unclear results or incomplete clinical data. The imaging examination was not perfect. Results of a large panel gene test without lung primary lesions. Re-treatment of patients.

Design outcomes

Primary

Measure	Time frame
Molecular phenotypic characteristics ;Different medical imaging sites of metastasis ;	—

Secondary

Measure	Time frame
Clinical stage;	—

Countries

China

Contacts

Public ContactYu Li

Shengjing Hospital of China Medical University

yulimail369@163.com+86 189 4025 9600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026